NovaBay Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NBY and other ETFs, options, and stocks.

About NBY

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase, CelleRx, and DERMAdoctor.

CEO

Justin M. Hall

CEOJustin M. Hall

Employees

Employees26

Headquarters

Emeryville, California

HeadquartersEmeryville, California

Founded

2000

Founded2000

Employees

Employees26

NBY Key Statistics

Market cap

2.81M

Market cap2.81M

Price-Earnings ratio

-0.02

Price-Earnings ratio-0.02

Dividend yield

—

Dividend yield—

Average volume

3.03M

Average volume3.03M

High today

$0.0797

High today$0.0797

Low today

$0.077

Low today$0.077

Open price

$0.077

Open price$0.077

Volume

67.69K

Volume67.69K

52 Week high

$1.42

52 Week high$1.42

52 Week low

$0.065

52 Week low$0.065

NBY News

TipRanks 7d

NovaBay receives NYSE American notice of non-compliance

NovaBay Pharmaceuticals announces that on April 18, it received a notice from the NYSE American stating that the company is below compliance with the NYSE Ameri...

Yahoo Finance 7d

NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity - Yahoo Finance

EMERYVILLE, Calif., April 19, 2024--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that on April 18, 2024 it received a notice f...